Immediate Impact

1 by Nobel laureates 6 from Science/Nature 68 hit
Sub-graph 1 of 23

Citing Papers

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
2023 Hit
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
2023 Hit
6 intermediate papers

Works of Jose Capellan being referenced

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals
2008
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects
2007
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jose Capellan 472 170 151 73 59 5 539
Murray Kimmel 455 1.0× 147 0.9× 115 0.8× 112 1.5× 61 1.0× 5 600
Avi Collins 451 1.0× 137 0.8× 111 0.7× 114 1.6× 43 0.7× 4 564
Nathaniel D. Lambert 367 0.8× 200 1.2× 194 1.3× 87 1.2× 144 2.4× 15 617
Iris A. de Bruijn 418 0.9× 104 0.6× 201 1.3× 54 0.7× 66 1.1× 12 510
Wilson Hu 457 1.0× 173 1.0× 127 0.8× 65 0.9× 43 0.7× 8 553
Pascale Van Belle 274 0.6× 109 0.6× 190 1.3× 25 0.3× 108 1.8× 7 463
Cynthia Strout 334 0.7× 162 1.0× 181 1.2× 33 0.5× 112 1.9× 9 551
Sandrine Tilman 440 0.9× 107 0.6× 136 0.9× 26 0.4× 85 1.4× 12 565
Edith C. Sannella 469 1.0× 215 1.3× 171 1.1× 115 1.6× 57 1.0× 13 602
Neil Formica 296 0.6× 180 1.1× 87 0.6× 49 0.7× 50 0.8× 11 457

All Works

Loading papers...

Rankless by CCL
2026